BioCardia
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of BioCardia generated cash of -$9,974,000, which is more than the previous year. Cash used in financing activities reached the amount of $3,726,000 last year. Net change in cash is therefore -$6,260,000.
Cash Flow
| 2014 | 214K | -53K | 7.81M |
|---|---|---|---|
| 2015 | 331K | -125K | 7.56M |
| 2016 | -5.52M | 18.92M | 4.39M |
| 2017 | -8.67M | -136K | 144K |
| 2018 | -11.06M | -66K | 3.80M |
| 2019 | -9.44M | -146K | 9.81M |
| 2020 | -12.35M | -32K | 28.21M |
| 2021 | -10.36M | -116K | 1.94M |
| 2022 | -10.56M | -70K | 5.12M |
| 2023 | -9.97M | -12K | 3.72M |
BCDAW Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 7.36M | 12.87M | 21.40M | 5.58M | 5.35M | 12.68M | 21.35M | 3.55M | 13.50M | 13.29M |
Operating activities | ||||||||||
Net income | -11.57M | -11.90M | -12.62M | -15.00M | -14.70M | -13.98M | -12.30M | -10.31M | 322K | 234K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 84K | 82K | 60K | 68K | 111K | 88K | 78K | 39K | 47K | 47K |
Stock-based compensation expense | 1.03M | 1.18M | 1.66M | 2.95M | 2.72M | 0 | 2.70M | 942K | 283K | 238K |
| Deferred income tax benefit | 1.03M | 1.18M | 1.66M | 2.95M | 2.72M | 0 | 2.70M | 942K | 283K | 238K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 138K | -54K | 85K | -85K | 127K | -179K | -21K | 33K | 65K | 78K |
Inventories | 0 | 0 | 507K | 4K | 136K | 49K | -56K | 27K | -82K | -37K |
Accounts payable | 184K | 4K | -239K | -168K | 171K | 119K | 377K | -17K | 9K | -17K |
Cash generated by operating activities | -9.97M | -10.56M | -10.36M | -12.35M | -9.44M | -11.06M | -8.67M | -5.52M | 331K | 214K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | -1.8M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -12K | -70K | -116K | -32K | -146K | -66K | -136K | 0 | -125K | -53K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | -18.92M | 18.92M | 0 | 0 |
Cash generated by investing activities | -12K | -70K | -116K | -32K | -146K | -66K | -136K | 18.92M | -125K | -53K |
Financing activities | ||||||||||
Common Stock Issued | 4.38M | 5.54M | 2.00M | 30.5M | 10.45M | 3.8M | 144K | 22K | 7.52M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | -160K | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -506K | 625K | 0 | 0 | 0 | 48K | 0 |
Cash used in financing activities | 3.72M | 5.12M | 1.94M | 28.21M | 9.81M | 3.80M | 144K | 4.39M | 7.56M | 7.81M |
Net Change In Cash | -6.26M | -5.50M | -8.53M | 15.82M | 227K | -7.33M | -8.66M | 17.79M | 331K | 214K |
Cash at end of period | 1.10M | 7.36M | 12.87M | 21.40M | 5.58M | 5.35M | 12.68M | 21.35M | 13.84M | 13.50M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |